Clinical studies have demonstrated that the plasma PAI-1 level is higher in patients with obesity as compared to control individuals (55.1 vs. 10.4 ng/mL, respectively), and, inversely, is reduced with body weight loss. This evidence concerns the gene SERPINE1 and obesity disorder.